Nasal Aspirate Testing Market Report 2026

Nasal Aspirate Testing Market Overview

• Nasal Aspirate Testing market size has reached to $1.36 billion in 2025 • Expected to grow to $2 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Surge In Rising Prevalence Of Respiratory Infections Fueling The Growth Of The Market Due To Higher Diagnostic Demand • Market Trend: Innovations In Automated Sample Preparation Systems To Boost Diagnostic Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nasal Aspirate Testing Market?

Nasal aspirate testing is a diagnostic procedure in which mucus and secretions are collected from the nasal passages to detect the presence of pathogens or abnormal cells, and the sample is typically obtained using a gentle suction device or syringe to ensure sufficient material for analysis. It is commonly used to identify respiratory infections, including viruses and bacteria, and to guide appropriate treatment. The main product types of nasal aspirate testing include instruments and consumables. Instruments refer to devices used to collect and analyze nasal samples for diagnostic purposes. The test types include molecular testing, antigen testing, microbiological culture testing, and allergy testing for age groups that include pediatric and adult. The various applications involved are infectious diseases, respiratory diseases, and other applications, and they are used by several end users, such as hospitals, diagnostic laboratories, research institutes, and other end users.

What Is The Nasal Aspirate Testing Market Growth Forecast?

The nasal aspirate testing market size is expected to see strong growth in the next few years. It will grow to $2 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to growing demand for high-sensitivity pathogen detection, increasing investment in rapid point-of-care diagnostics, rising integration of AI-assisted diagnostic analysis, expansion of infectious disease surveillance programs, increasing focus on personalized respiratory treatment approaches. Major trends in the forecast period include increasing adoption of rapid molecular diagnostic testing, rising demand for pediatric respiratory infection screening, growing use of automated sample processing systems, expansion of point-of-care respiratory testing, rising focus on early detection of infectious diseases.

Global Nasal Aspirate Testing Market Segmentation

1) By Product Type: Instruments, Consumables 2) By Test Type: Molecular Testing, Antigen Testing, Microbiological Culture Testing, Allergy Testing 3) By Age Group: Pediatric, Adult 4) By Application: Infectious Diseases, Respiratory Diseases, Other Applications 5) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End Users Subsegments: 1) By Instruments: Nasal Aspirate Collection Devices, Suction Pumps And Vacuum Systems, Sample Processing Analyzers, Molecular Diagnostic Instruments, Automated Laboratory Workstations 2) By Consumables: Sterile Suction Catheters, Sample Collection Tubes, Transport Media Kits, Reagents And Assay Kits, Disposable Filters And Tips

What Is The Driver Of The Nasal Aspirate Testing Market?

The rising prevalence of respiratory infections is expected to propel the growth of the nasal aspirate testing market going forward. Respiratory infections are illnesses caused by viral or bacterial pathogens that affect the nasal passages, throat, and lungs, leading to symptoms such as cough, fever, and difficulty breathing. The incidence of these infections continues to increase due to the widespread circulation of seasonal respiratory viruses, particularly in densely populated and high-contact settings where transmission is more likely. Nasal aspirate testing supports the effective management of respiratory infections by enabling clinicians to collect concentrated respiratory samples from the nasal passages, which improves pathogen detection accuracy, facilitates early and precise diagnosis, and helps guide timely treatment decisions. For instance, in June 2024, according to the UK Health Security Agency, a UK-based government agency, approximately 1,681 patients were admitted to critical care with confirmed influenza in England between week 40 of 2022 and week 15 of 2023. Therefore, a rising prevalence of respiratory infections is expected to drive the growth of the nasal aspirate testing industry.

Key Players In The Global Nasal Aspirate Testing Market

Major companies operating in the nasal aspirate testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson Company, bioMérieux SA, Hologic Inc., QuidelOrtho Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., DiaSorin S.p.A., SD Biosensor Inc., Meridian Bioscience Inc., Seegene Inc., Sekisui Diagnostics LLC, QuantuMDx Group Limited, Altona Diagnostics GmbH, Fast Track Diagnostics Ltd., Sherlock Biosciences Inc., Coris BioConcept S.A.

Global Nasal Aspirate Testing Market Trends and Insights

Major companies operating in the nasal aspirate testing market are focusing on developing innovative solutions such as, automated sample preparation systems to increase testing speed, accuracy, and standardization. Automated sample preparation systems are technologies that streamline the collection, processing, and preparation of nasal aspirate samples with minimal manual intervention, helping reduce errors, save time, and improve consistency and accuracy in diagnostic testing. For instance, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, launched the Thermo Scientific KingFisher Apex Automated Sample Preparation Solution, an innovative system aimed at simplifying and automating respiratory diagnostic testing. The KingFisher Apex is an advanced automated sample preparation system that combines magnetic particle technology with customizable protocols, allowing labs to process multiple sample types with minimal hands-on time, reduce errors, and accelerate diagnostic turnaround. As a next-generation automated sample preparation system, it features a modular design for scalability, compatibility with a wide range of assays, and built-in software for workflow monitoring and optimization, making it particularly valuable for clinical, research, and high-volume testing environments.

What Are Latest Mergers And Acquisitions In The Nasal Aspirate Testing Market?

In January 2023, SD Biosensor Inc., a South Korea–based in vitro diagnostics and healthcare technology company, and SJL Partners LLC, a South-Korea-based private equity firm, acquired Meridian Bioscience Inc. for an undisclosed amount. With this acquisition, the consortium aimed to accelerate SD Biosensor’s strategic entry into the U.S. in vitro diagnostic market and expand its global diagnostic capabilities by combining Meridian’s established U.S. distribution network and product portfolio with SD Biosensor’s development and manufacturing strengths. Meridian Bioscience Inc. is a US-based life science and diagnostics company that specializes in providing nasal aspirate testing.

Regional Insights

North America was the largest region in the nasal aspirate testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nasal Aspirate Testing Market?

The nasal aspirate testing market consists of sales of collection kits, diagnostic reagents and consumables, molecular testing kits, rapid antigen test kits, and laboratory equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Nasal Aspirate Testing Market Report 2026?

The nasal aspirate testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nasal aspirate testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.